Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1071-1071
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3888-3888
Open Access | Times Cited: 69
Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10846-10846
Open Access | Times Cited: 56
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
The Role of MUC1 in Renal Cell Carcinoma
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 34
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Urinary Micro-RNAs As Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
(2023)
Open Access | Times Cited: 31
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
Savio Domenico Pandolfo, Clara Cerrato, Zhenjie Wu, et al.
Asian journal of urology (2023) Vol. 10, Iss. 4, pp. 390-406
Open Access | Times Cited: 29
The association between the triglyceride–glucose index and prognosis in postoperative renal cell carcinoma patients: a retrospective cohort study
Guoliang Qin, Zhuang Sun, Yuxiang Jin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
MUC1 Drives the Progression and Chemoresistance of Clear Cell Renal Carcinomas
Emma Bourdon, Thomas Swierczewski, Marine Goujon, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 391-391
Open Access | Times Cited: 4
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients
Lei Ren, Jinwen Liu, Qingyuan Lin, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma
Simone C. Kleinendorst, Egbert Oosterwijk, Janneke D.M. Molkenboer‐Kuenen, et al.
Theranostics (2024) Vol. 14, Iss. 9, pp. 3693-3707
Open Access | Times Cited: 4
Bioinformatics analysis of mitochondrial metabolism-related genes demonstrates their importance in renal cell carcinoma
Mohsen Ahmadi, Maryam Motallebinezhad, Pegah Mousavi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients
Natalie Wiley, Mladen Zečević, Vivian Ho, et al.
European Radiology (2025)
Closed Access
Potential prognostic and immunologic significances of ADAM8 in clear cell renal cell carcinoma
M CHU, Zhi Lei Zhang, Zhi Qiang Wang, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41375-e41375
Open Access
Simultaneous bilateral robotic-assisted partial nephrectomy using a dual stepwise transperitoneal and retroperitoneal approaches: A case report
Francesco Dinale, Annalisa Patera, Tommaso Bocchialini, et al.
Laparoscopic Endoscopic and Robotic Surgery (2025)
Open Access
Glycogen metabolism genes as a molecular signature for subtyping, prognostic prediction, and immunotherapy selection in clear cell renal cell carcinoma
Fangjing Ni, Xiangyin Tan, Jian Zhang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma
Giuseppe Lucarelli, Francesco M. Lasorsa, Martina Milella, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Open Access
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Identification of ferroptosis-related gene signatures as a novel prognostic model for clear cell renal cell carcinoma
Xiaoxiao Du, Haoyuan Cao, Yujie Zhou, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
FADS1, a lipid metabolism-related diagnostic biomarker in KIRC
Tianmin Yang, Kai Sun, Fan Peng, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress
Bei Feng, Haiying Guo, Ning Yu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Disulfidptosis, a novel regulated cell death to predict survival and therapeutic response in kidney renal clear cell carcinoma
Wen-Jia Chen, Jiaxin Shen, Hui Lin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The percentage abundance of sarcomatoid component has a prognostic role in grade 4 non-metastatic clear cell-renal carcinoma
Giuseppe Lucarelli, Francesco M. Lasorsa, Monica Rutigliano, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Open Access
Targeting the complement system: notes on therapeutic strategies for renal cancer
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Future Medicinal Chemistry (2025), pp. 1-3
Closed Access
Page 1 - Next Page

Scroll to top